708TiP BD4QoL: A multicenter randomized trial for monitoring quality of life (QoL) by intelligent tools in head and neck cancer (HNC) survivors after curative treatment


HNC survivors suffer from high physical, psychological and socioeconomic burdens. Achieving cancer-free survival with an optimal QoL is the primary goal for HNC patients (pts) management. Therefore, maintaining lifelong surveillance is critical. This can be carried out by advanced analysis of environmental, emotional and behavioral data unobtrusively collected from mobile devices. The aim of this clinical trial is to reduce, with specific non-invasive tools (i.e., their mobile devices), the proportion of HNC survivors experiencing a clinically meaningful reduction in QoL during post-treatment follow-up.